MMCLUB

[Rawnoc]

Some REPR highlights from the 10Q that suggest a large jump in sales and profits coming IMO:

"hiring of a sales associate to promote the Freedom60 in Europe" <~~~~Daisy set???
"additional staff including two domestic sales associates"
"We believe the Freedom60 continues to find a solid following in the subcutaneous immune globulin market and with the introduction of a new 20% IgG drug released early this year, this market is expected to continue to increase both domestically and internationally."
"The Freedom60 use for Primary Immune Deficiency by injecting immune globulin (IgG) under the skin as a subcutaneous administration has seen increased usage especially in Europe over the past year and is expected to continue with the introduction a new 20% solution of IgG at the beginning of this year. We have been told by meeting users at trade shows that his method has provided them with vastly improved quality of life with much fewer unpleasant side effects over the traditional intravenous route."
"In May, we traveled to Ft. Lauderdale, FL for the INS: Infusion Nurses Society Annual Meeting and Industrial Exhibition; the largest meeting for infusion nursing professionals in the United States." <~~~~one of many recent trade shows